Amaxa Nucleofector device

Friday, 28 May, 2010 | Supplied by: Capsugel Australia Pty Ltd


Amaxa’s Nucleofector technology is a highly efficient non-viral method for transfection, based on two components: the Nucleofector device that delivers unique electrical parameters and Nucleofector kits that contain cell-type-specific Nucleofector solutions.

The electrical parameters of the Nucleofector are claimed to be different from other electroporation devices. Each electrical setting is displayed as a distinct program which has been adapted to the requirements of a particular cell type. Electrical parameters are preprogrammed into the Nucleofector, thus optimisation by the user is not necessary.

The device weighs 2.6 kg and is sized to fit under a sterile hood, suitable for sterile work with cells.

Online: www.capsugel.com
Phone: 1300 657508
Related Products

Enzo Life Sciences SUPERKILLERTRAIL protein (soluble) (human), (recombinant)

Enzo Life Sciences' SUPERKILLERTRAIL (soluble) (human), (recombinant) is an enhanced ligand...

Diaclone ELISpot Kits

Diaclone's ELISpot Kits are highly specific immunoassays for the analysis of the production...

Bio-Rad Laboratories Bio-Plex Pro Human SARS-CoV-2 Variant Neutralization Antibody Assays

The assays allow scientists to measure neutralising antibodies quickly and efficiently against...


  • All content Copyright © 2022 Westwick-Farrow Pty Ltd